Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Hits FDA Hurdle, Slips 4.5% Pre-Market - TipRanks.com
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges
S&P Global Ratings affirms Teva Pharmaceutical Industries at "BB-" (Local Currency LT credit rating); outlook stable
Teva woes deepen as Fitch cuts credit rating to junk | The Times of Israel
Credit Trends: Downgrade Potential Rises To All-Time High On Sharp, Deep Economic Slowdown | S&P Global Ratings
Teva Pharmaceutical Industries Limited Credit Ratings :: Fitch Ratings
Teva Shut Down New York, Washington Offices, Says CEO | Ctech
Teva's Debt Cut to Junk by Moody's, Adding to Drugmaker's Woes - Bloomberg
Teva's Debt Cut to Junk by Moody's, Adding to Drugmaker's Woes - Bloomberg
Teva jumps after Wall Street upgrades, analysts say stock 'too cheap to ignore'
Credit Trends: Downgrade Potential Rises To All-Time High On Sharp, Deep Economic Slowdown | S&P Global Ratings
Fitch Downgrades Teva to Junk Rating | Ctech
Credit Trends: Downgrade Potential Rises To All-Time High On Sharp, Deep Economic Slowdown | S&P Global Ratings
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO
Teva Pharmaceutical Stock: Hinting A Payoff Potential (NYSE:TEVA) | Seeking Alpha
Teva Shakes Up C-Suite in Restructuring | BioSpace
Rating Agencies Exacerbate The Covid Crisis for Sovereigns - Track Live Bond Prices Online with BondEValue App - credit downgrades, credit ratings, sovereign bonds, sovereign ratings
Teva Pharmaceutical S&P rating outlook changed to stable | Seeking Alpha
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
